Brian J. Caveney - 05 Nov 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: EVP, President of Diagnostics
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Brian J. Caveney
Issuer symbol: LH
Transactions as of: 05 Nov 2022
Net transactions value: -$208,990
Form type: 4
Filing time: 08 Nov 2022, 15:20:08 UTC
Previous filing: 13 Sep 2022
Next filing: 06 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LH	Common Stock	Options Exercise		+2,010	+14%		16,292	05 Nov 2022	Direct	F1
transaction	LH	Common Stock	Tax liability	$208,990	-894	-5.5%	$233.77	15,398	07 Nov 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Restricted Stock Unit	Options Exercise	$0	-2,010	-43%	$0.000000	2,717	05 Nov 2022	Common Stock	2,010		Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2	Stock withholding to satisfy tax withholding obligations.
F3	The Restricted Stock Units vested in three equal annual installments beginning on November 5, 2020 and are now fully vested.
F4	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.